Introduction

88
HIV-1 RNA is detected in the cerebrospinal fluid (CSF) throughout the course of untreated systemic 89 infection, beginning early after initial exposure [1] [2] [3] concentrations in untreated PLWH average more than 10-fold lower than those of plasma, [5, 10, 11] .
94
Combination ART is generally very effective in suppressing CNS HIV-1 infection, so that treatment that 95 reduces plasma HIV-1 to below the clinical LLoQ is similarly effective in eliminating 'clinically detectable'
96
CSF HIV-1 RNA. In our earlier studies of individuals 'failing' therapy, ART appeared to disproportionately 97 lower CSF HIV-1 RNA compared to plasma [12, 13] . Even when more sensitive assays have been used to 98 measure HIV-1 RNA, detection in the CSF was less common and at lower levels than that in plasma,
99
consistent with the general treatment effectiveness on CNS infection [9, 14] .
100
However, there are notable exceptions to this effective and proportionate effect of ART on CSF HIV-1 101 infection that have been collectively designated CSF escape in which the concentration of HIV-1 in CSF 102 remains above the LLoQ and equal to or greater than that in plasma in the face of therapeutic plasma 103 virus suppression [15] [16] [17] . This was coherently defined in a report of 11 treated patients presenting with 104 a variety of neurological symptoms and signs who exhibited higher CSF than plasma HIV-1 RNA 105 concentrations [18] . Additional reports preceded [19] and have followed [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , and this condition is 106 now termed neurosymptomatic CSF escape based on the clinical presentation of neurological deficits in 107 the presence of detectable CSF HIV-1 RNA despite systemic viral suppression [15, 17, 30] . This is clinically 108 the most important type of CSF escape and can present with major neurological deficits and imaging 109 abnormalities [20] . It at least partially overlaps with the neuropathological entity, CD8 encephalitis [31,
110 32], and involves replication of HIV-1 within the CNS despite systemic viral control. Unlike HIV-1 111 encephalitis that may complicate late untreated HIV-1 infection [33, 34] , neurosymptomatic escape 112 usually develops in individuals with blood CD4+ T lymphocyte counts above the 200 cells per µL 113 threshold defining AIDS, and CD8+ T cell infiltration may be very prominent [31] . In these cases, it is 114 presumed that the neurological symptoms and signs are causally related to CNS HIV-1 infection that is 115 not effectively controlled by ART despite systemic efficacy, often in concert with a robust inflammatory 116 reaction. This is supported by histopathological identification of HIV-1 in brain tissue of some cases,
117
including some of those designated as CD8 encephalitis that share the CSF escape profile [32] . HIV-1 causality is also supported by the frequent therapeutic benefit of treatment modification on 119 neurological symptoms and signs [18, 20, 29] 
167
The prominent inflammatory aspect of HZ provides a relatively common setting to examine the effects 168 of focal inflammation within the neuraxis on CSF HIV-1 concentrations, and we therefore undertook a 169 review of our experience with HZ in PLWH who underwent LP and CSF analysis. 
182
On therapy no escape: as in a) above; but b) CSF HIV-1 RNA below the laboratory LLoQ, or CSF < 183 plasma HIV-1 RNA.
184
Off ART:
185 CSF discordance: a) untreated (naïve or off ART >8 months); and b) CSF > plasma HIV-1 RNA.
186
No CSF discordance: untreated as in a) above; but b) with CSF < plasma HIV-1 RNA.
187
Cross-sectional analysis included data from the first LP after the onset of HZ. CSF and plasma HIV-1 RNA
188
were measured in all subjects using the Roche Cobas Taqman assay with the LLoQ of 20 copies/mL; a 189 value of 19 copies/mL was assigned as the default value for any levels below 20 in calculations and 190 descriptive statistics. The CSF:plasma ratio was calculated using log 10 values: log 10 CSF HIV-1 RNA -log 10 191 plasma HIV-1 RNA.
192
ART regimen at the times of HZ outbreak and CSF sampling were available for all subjects. CSF white analyses, data were log 10 transformed; in the case of CSF WBCs, when the initial laboratory value was 207 zero, we substituted a value of one for analysis and graphing of the transformed data.
208
Results
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209 Cross-sectional study population. We identified 25 HIV-1-infected individuals who underwent LP 210 within 150 days after the onset of HZ rash: 9 on and 16 off ART (Table 1) . These were divided into the 4 211 categories defined above by treatment status and the relation of CSF to plasma HIV-1 RNA levels. Most
212
were treated with a course of valacyclovir or acyclovir after recognition of the rash. Table 1 lists the 213 salient background data for each of the subjects grouped according to these four categories. The 214 neurological symptoms and signs in the HZ patients were consistent with the zoster itself, and none 215 showed overt evidence of extension of the infection into the CNS or more remote dissemination. All included at the bottom of the Table 1 . In those with HZ the median age was 42 years and the median 219 time from rash outbreak to LP was 18 days with a range from one to 150 days. The patient with 220 neuroborreliosis was a bit older, at 62 years. In general, the demographics, including sex, race and 221 ethnicity, reflected those of HIV-1 infection in Sweden and of the Gothenburg cohort. There were 16 222 men and 9 women including 18 Caucasian, 6 Black-African, 2 Asian and one Latin-Hispanic.
223
[Insert Table 1 here.]
224
HIV-1 RNA concentrations in the four groups. Figure 
228
RNA in the two fluids, higher in the CSF than plasma in the escape and discordant groups (left panels, A 229 and C) and lower in the no escape and nondiscordant groups (right panels, B and D). The nondiscordant 230 group exhibited the more typical negative CSF:plasma ratio, here with a more than 10-fold mean higher 231 plasma than CSF HIV-1 RNA concentration. In accordance with the grouping definition, the plasma HIV-1
232
RNAs in the treated groups were similar. Only one of the escape groups was not suppressed to the 233 laboratory LLoQ of <20 HIV-1 RNA copies per mL (or 1.30 log10 copies per mL) in plasma, but the mean 234 CSF HIV-1 RNA in the HZ escape group was 2.68 log 10 copies per mL, a modest but distinct level of CSF 235 escape from therapy, particularly in comparison to the fully suppressed CSF levels in the no escape 236 group. As expected, the plasma HIV-1 RNA concentrations were higher in the two untreated groups 237 (mean of 4.69 log 10 copies per mL in the discordant and 5.14 log 10 copies per mL in nondiscordant) but 238 with the CSF distinctly higher than its companion plasma in the discordant samples while the plasma
239
HIV-1 RNA was higher than that of the CSF in the nondiscordant group. This figure not only shows the
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Page 10 240 relationships between CSF and plasma HIV-1 RNA that conform to their group definitions but 241 emphasizes the distinct differences among these four groups that serves as the basis for comparing their 242 other characteristics.
243
[Insert Figure 1 here.]
244
In order to better understand the reversal of CSF:plasma HIV-1 RNA ratios by HZ in some, but not all, of (Figure 2A ), so that higher CSF WBC counts were associated with higher CSF
251
HIV-1 than plasma HIV-1 RNA levels in both of these group pairings.
252
[Insert Figure 2 here.]
253
In order to examine this further, we separately assessed the relationship of the CSF HIV-1 RNA levels to 254 the CSF WBC counts in the treated (escape and no escape) and untreated (discordant and non-255 discordant) groups using linear regression after log 10 transformations ( Figure 3A ). This showed a strong 256 correlation within each of these two paired groups, indicating an effect on the CSF HIV-1 RNA 257 concentrations across the range of CSF WBC counts in both the treated and untreated individuals. Both 258 the escape and discordant individuals were in the higher CSF WBC range while the non-escape and non-259 discordant were in the lower CSF WBC range of each of these lines which were separated by nearly 3 260 log 10 copies/mL of HIV-1 RNA related to the effect of systemic treatment.
261
[Insert Figure 3 here.]
262
Because of this separation between the two sample pairs, we next examined the correlation of the CSF
263
WBC counts with the ratios of CSF to plasma HIV-1 RNA (expressed as the log 10 difference between CSF 264 and plasma HIV-1 RNA) across the entire sample set as shown in Figure 3B . This revealed a strong,
265
correlation that included all four subject groups along a single regression slope. Taken together these 266 data suggest that the plasma HIV-1 (whether treated or untreated) set the overall level of infection in 267 the plasma, but that the CSF WBC response then strongly influenced the relationship of the CSF HIV-1
268 RNA concentration to that plasma level. This WBC effect resulted in a 'reversed' CSF-plasma ratio (i.e.,
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271
CSF neopterin. The Gothenburg cohort study included measurement of CSF neopterin at most LP visits.
272
THis is a sensitive measure of enhanced immune activation-inflammation in the CNS during HIV-1
273
infection [50] . In this small series, the CSF neopterin concentrations were above normal in most of those 274 with HZ and higher in the escape and discordant groups than their non-escape and non-discordant 275 counterparts, mainly related to two high values in each of these groups, and overall the group pairs
276
were not significantly different ( Figure 2B ). The CSF neopterin did correlate with the CSF:plasma HIV-1 277 ratio, though not as strongly as the CSF WBC count (linear regression P = 0.0184; R 2 = 0.231). Thus, CSF 278 neopterin measurements supported the association of inflammation with the CSF relation to plasma
279
HIV-1 RNA, but were not as clear a predictor as the CSF WBC count, though the CSF neopterin and WBC 280 counts, themselves, were strongly correlated (P= 0.0001; Spearman r =0.7195).
281
Blood CD4+ T-lymphocyte count. The blood CD4+ T-cell counts of the HZ patients were mostly above 282 the levels predisposing to opportunistic infections, with a median near 400 cells/µL in the treated groups 283 and 350 cells/µL in the discordant group off ART ( Figure 2C ). [52] , we reasoned that the CSF NfL levels in this setting would 294 reflect the activity and severity of the HZ ganglioneuritis and perhaps its distance from the LP sampling 295 site. We also more directly examined the timing of the LP in relation to the rash outbreak and the 296 distance of the rash from the LP sampling site using the simple scale described above to see if any of 297 these measures correlated with CSF HIV-1 RNA. However, none showed a clear correlation ( Figure 2D-F) .
298
While the severity and timing of the ganglioneuritis and its distance from the LP site are likely interactive 299 and interrelated, with the limited sampling of this cross-sectional study we did not show a clear individual relation to the CSF HIV-1 RNA or its relation to plasma HIV-1 RNA. If these factors did indeed 301 exert an effect on the CSF HIV-1 RNA, it was not as robust as the CSF WBC reaction.
302
Longitudinal observation. CSF and blood samples from one of the discordant subjects with HZ (SID 303 #5348 in the Table) were obtained at several study visits before and after the index HZ LP included in the lymphocyte count had risen from a nadir of 40 to 300 cells/µL, his plasma HIV-1 RNA was suppressed to 307 <20 copies/mL, but his CSF HIV-1 RNA was elevated at 1,920 copies/mL despite having been 308 undetectable for at least a year and one-half. The CSF HIV-1 RNA then remained elevated for 400 days at 309 62 and 72 copies/mL but returned to below the detection limit by the next LP at 868 days and through 310 the duration of follow-up out to 11 years later ( Figure 4A ). The plasma HIV-1 RNA remained below the 311 LLoQ throughout this long period of observation. The CSF NfL concentration rose early after initial 312 therapy, but then decreased to its basal level before it again rose during the HZ episode, remaining 313 above the basal level through 400 days before returning to baseline after longer follow-up; none of 314 these measurements were actually above the upper limit of age-corrected normal levels of NfL [53]. This
315
presumably reflected the protracted course of zoster ganglioneuritis ( Figure 4A ). The CSF WBC count 316 followed a time course very similar to that of the CSF HIV-1 RNA concentration, increasing initially to 67 317 cells/mL at the index HZ LP, and then subsiding to 28 and 15 cells/mL over the ensuing year before 318 returning to normal along with the CSF HIV-1 RNA and NfL ( Figure 4B ). CSF neopterin was elevated 319 above the plasma concentration before treatment, fell with ART but then also rose over the course of 320 the HZ before falling again after 2 years. While the plasma neopterin was also elevated before treatment 321 initiation and fell with ART, it did not change its trajectory appreciably during the HZ episode, supporting Discussion This retrospective analysis indicates that HZ was associated with an increase in local HIV-1 production 331 within the CSF compartment and strongly suggests that this was mediated through the local 332 inflammatory response to VZV reactivation, and particularly by the lymphocytic pleocytosis. In this series 333 of individuals, a more robust inflammatory response associated with an increase in CSF HIV-1 RNA 334 concentration in relation to that of plasma HIV-1 RNA both in those on ART with secondary CSF escape 335 and those off treatment with CSF discordance. Our analysis suggests that this augmentation of local HIV-336 1 production was associated with the WBC inflammatory cell response to HZ that then determined the 
366
Our case series was small, but overall more than two-thirds of our PLWH and HZ exhibited pleocytosis 367 (defined as a CSF WBC counts >5 cells/µL), a higher frequency than the nearly 50% reported in non-HIV 368 patients [42] . In our subjects without escape or discordance the frequency of pleocytosis was similar to 369 that reported in non-HIV subjects, 3 of 5 and 4 of 8 respectively. However, in the escape and 370 discordance groups all had abnormal CSF WBC counts (median of 43 and 60) that were higher than in 371 the non-escape and non-discordant groups (median of 14 and 4 cells/µL).
372
Common to both the treated and untreated groups, there was a relationship of the CSF WBC count to 373 the CSF viral load and to the ratio of CSF to plasma HIV-1 RNA concentrations. Both treated and 374 untreated groups showed a threshold between 10-30 cells/µL at which this ratio transitioned to higher 375 CSF than plasma HIV-1 RNA concentrations that defined CSF escape or discordance depending on Figure 3B ). This analysis also argues for the 384 mechanistic similarity of CSF escape and discordance in this setting.
385
HZ is an inflammatory disorder in those without and with HIV-1 infection that begins in the dorsal root 386 ganglion, spreads centrifugally along the peripheral nerve, and seeds the skin of the related dermatome,
387
leading to the characteristic rash. Infection also spreads centripetally to the nerve root and, to a variable 388 degree, beyond, into the spinal cord or brain stem [58] [59] [60] . It also may spill over into the leptomeninges,
389
producing an 'aseptic' meningitis.
390
Our leading hypothesis in explaining the development of CSF escape and discordance in this setting is 391 that HZ provokes local inflammation along this pathway that includes CD4+ T-cells, an important Secondary CSF escape Page 15
392 component in VZV defense [61] [62] [63] . Some of these CD4+ cells are most likely VZV-specific, but others 393 may also include bystander cells with other antigen specificities responding to the heightened 394 inflammatory milieu. It remains to be seen which population of these cells contains the HIV-1 provirus.
395
With activation these cells may exhibit clonal expansion releasing HIV-1 of limited genotypes or they 
411
Here, as in other settings, a crucial question is whether CSF pleocytosis was the cause of or the response 412 to intrathecal HIV-1 infection. Following the arguments above, we favor the former: that the CSF WBCs 413 importantly contributed to the level of CSF HIV-1 RNA. In the HZ setting (and the two other included 414 infections) the secondary infection within the neuraxis was likely a sufficient explanation for the CSF 415 pleocytosis, and the level of this CSF WBC response then led to the enhanced CSF HIV-1 RNA production.
416
It is, however, theoretically possible that the local HIV-1 replication initiated by the HZ then further 
421
Our efforts to define the influence of the timing of the HZ rash on the CSF HIV-1 RNA concentration and 422 its relation to that of plasma did not provide a clear definition of this factor, though the numbers were small and the timing of LPs inconsistent. However, the aggregate cross-sectional experience with escape 424 and discordance together with the longitudinal observations show that the effect of HZ on CSF HIV-1
425
RNA, in parallel with the inflammatory reaction, is protracted, lasting up to the 5 month limit of our 426 study definition and beyond one year in the longitudinal example in Figure 4 . The elevation of the age-427 corrected CSF NfL concentrations to above normal or baseline limits in more than half of all the HZ 428 cases, including out to 150 days in one of the individuals with CSF escape, also documents the prolonged 429 time course of HZ, and the longitudinal case shows how this injury also can parallel the CSF escape. We 430 did not detect a clear overall correlation of either the NfL concentration or the distance of the HZ rash 431 from the LP needle with the magnitude of the effect on CSF HIV-1 RNA. While we presume that the 432 inflammatory focus, including the focus of HIV-1 RNA release, is anatomically circumscribed, our data 433 were insufficient to define this quantitatively and may have been obscured by ready diffusion of HIV-1
434
RNA and other analytes within the CSF space.
435
The two non-HZ escape cases included in this analysis exhibited features that align with the four 436 individuals with HZ-related secondary escape, but also included some differences. Most notably, they 437 shared the association of the CSF HIV-1 RNA concentrations with the WBC counts, enough to fit into the 438 linear correlation between these two key variables (Figure 3 ). However, the HSV-2 encephalitis case suggest that the robust local or regional inflammatory response to VZV gives rise to secondary HIV-1 481 production that is reflected in CSF. They also demonstrate that secondary escape is an entity worthy of 482 further study, including virological and immunological dissection that may contribute to a broader 483 understanding of some of the features of a contributing source of CSF HIV-1 infection. while the plasma neopterin did not alter its trajectory with the HZ episode.
Figure Legends
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